A Phase 2 interventional study of Meridol and Colgate Cavity Protection in Gingivitis and Plaque, sponsored by Colgate Palmolive. Completed at 1 site in Thailand. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-21.
Sponsored by Colgate Palmolive · Phase 2, Interventional, and Treatment
The objective of this six-month clinical research study is to evaluate the clinical efficacy of two dentifrices - Toothpaste containing zinc lactate and Colgate Cavity Protection Toothpaste in reducing gingivitis and dental plaque in adults.
590 studies on the registry are indexed under Gingivitis; 104 are open to participants now.
This study's enrollment of 92 is above the median of 64 across 478 interventional studies indexed under Gingivitis.
Browse Gingivitis studies →Colgate Palmolive is the lead sponsor of 114 studies on the registry; 12 are open to participants now.
Of its 33 completed or terminated interventional studies of FDA-regulated products, 2 (6%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Toothpaste
Drug: Meridol
Toothpaste
Drug: Colgate Cavity Protection
toothpaste
toothpaste
Gingivitis Assessment
A Loe-Silness Gingival Index score from 0 to 3 will be assigned by the examining dentist to all scoreable surfaces of the maxillary and mandibular teeth using a dental light and dental mirror.
Time frame: baseline, 3 months and 6 months
Plaque Assessment
A Quigley-Hein Plaque Index score of 0 to 5 will be assigned to all scoreable disclosed surfaces of the maxillary and mandibular teeth using a dental light and dental mirror
Time frame: baseline, 3 months and 6 months
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Colgate Palmolive